Development and Therapeutic Potential of NUAKs Inhibitors

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• NUAK1 (ARK5) and NUAK2 (SNARK) are AMPK family protein kinases involved in diverse physiological and cellular processes.
• Dysregulation of NUAK isoforms is implicated in neurodegeneration, metastatic cancer, and diabetes.
• These isoforms represent significant therapeutic targets for metabolic diseases and cancers.

Purpose of the Study:

• To review the homology, expression, structure, and characteristics of NUAK isoforms.
• To elucidate the involvement of NUAK isoforms in critical biological functions and disease pathogenesis.
• To summarize applications of targeting NUAK isoforms for treating cancers and neurodegenerative disorders.

Main Methods:

• Literature review and analysis of scientific publications.
• Discussion of NUAK isoform homology, expression, and structure.
• Examination of mechanistic findings related to NUAK isoform function in disease.

Main Results:

• NUAK isoforms play overlapping roles in cellular events, with dysregulation contributing to disease.
• Targeting NUAK isoforms shows potential for treating multiple cancers and neurodegenerative conditions.
• Small molecule inhibitors targeting NUAK isoforms have been developed.

Conclusions:

• NUAK isoforms are crucial in cellular functions and disease development.
• Targeting NUAK isoforms presents a viable therapeutic avenue for significant human diseases.
• Further research into NUAK isoform inhibition is warranted for therapeutic development.